MarketCapTrends
TRDA

Entrada Therapeutics Inc.

NASDAQ · Healthcare

Entrada Therapeutics Inc. annual/quarterly net income history and growth rate from 2023 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.

  • Entrada Therapeutics Inc. net income for the quarter ending March 31, 2026 was -39.7 M, a 128.93% increase year-over-year.
  • Entrada Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -144.3 M, a 244.37% decrease year-over-year.
  • Entrada Therapeutics Inc. annual net income for 2025 was -143.8 M, a 319.04% decrease from 2024.
  • Entrada Therapeutics Inc. annual net income for 2024 was 65.6 M, a 1081.69% decrease from 2023.
  • Entrada Therapeutics Inc. annual net income for 2023 was -6.7 M.
Net Income
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %